Skip to main content

Table 1 Baseline characteristics of 19,902 males and 7086 females

From: Association of alcohol consumption with the incidence of proteinuria and chronic kidney disease: a retrospective cohort study in Japan

 

Male

Female

Daily alcohol consumption categories (g of alcohol)

Daily alcohol consumption categories (g of alcohol)

No

 < 23 g

23–46

 ≥ 46

No

 < 23 g

23–46

 ≥ 46

Number

7352

6337

4252

1761

4017

1952

755

362

Age (years) *

39 (31–49)

40 (32–50)

47 (39–57)

48 (40–57)

42 (35–51)

42 (35–50)

46 (39–55)

47 (39–55)

Smoking, n (%) *

 Never

2793 (38.0)

2109 (33.3)

757 (17.8)

195 (11.1)

3258 (81.1)

1500 (76.8)

486 (64.4)

239 (66.0)

 Former

1714 (23.3)

1862 (29.4)

1580 (37.2)

647 (36.7)

404 (10.1)

278 (14.2)

136 (18.0)

64 (17.7)

 Current

2803 (38.1)

2366 (37.3)

1915 (45.0)

919 (52.2)

301 (7.5)

170 (8.7)

127 (16.8)

56 (15.5)

 Body mass index, kg/m2*

23.3 (21.1–25.9)

23.1 (21.3–25.3)

23.3 (21.6–25.3)

23.3 (21.5–25.3)

21.1 (19.3–23.6)

21.1 (19.3–23.4)

21.6 (19.8–24.1)

21.9 (19.8–24.3)

 Systolic BP, mmHg *

119 (109–130)

119 (110–130)

120 (110–132)

121 (111–132)

112 (102–125)

112 (102–124)

112 (102–125)

115 (104–126)

 Diastolic BP, mmHg *

72 (65–81)

73 (66–81)

75 (67–84)

76 (67–84)

68 (61–76)

68 (61–76)

68 (61–77)

70 (61–77)

 Uric acid, mg/dL

5.8 (4.9–6.7)

5.8 (5.0–6.7)

5.9 (5.0–6.7)

5.9 (5.0–6.7)

4.5 (3.8–5.5)

4.6 (3.8–5.5)

4.4 (3.7–5.4)

4.5 (3.8–5.3)

 Total cholesterol, mg/dL *

196 (173–222)

197 (175–221)

203 (182–226)

205 (183–227)

199 (178–225)

199 (176–223)

202 (179–228)

202 (180–230)

 Triglyceride, mg/dL *

96 (66–142)

96 (66–142)

102 (71–152)

109 (74–171)

70 (51–98)

68 (51–95)

76 (59–105)

84 (61–127)

 Hemoglobin A1c, % *

5.4 (5.2–5.7)

5.4 (5.2–5.6)

5.4 (5.2–5.7)

5.4 (5.2–5.7)

5.4 (5.2–5.7)

5.4 (5.2–5.6)

5.4 (5.2–5.6)

5.4 (5.2–5.7)

 eGFR, mL/min/1.73 m2*

87 (77–97)

86 (76–96)

83 (75–94)

85 (76–96)

75 (68–84)

76 (68–84)

73 (67–82)

76 (69–84)

Current treatments

 Hypertension, n (%) *

426 (5.8)

500

(7.9)

611 (14.4)

306 (17.4)

188 (4.7)

95 (4.9)

77 (10.2)

42 (11.6)

 Dyslipidemia, n (%) *

242 (3.3)

275 (4.3)

192 (4.5)

84 (4.8)

147 (3.7)

63 (3.2)

43 (5.7)

26 (7.2)

 Diabetes mellitus, n (%) *

210 (2.9)

176 (2.8)

146 (3.4)

69 (3.9)

50 (1.2)

19 (1.0)

12 (1.6)

8 (2.2)

 CVD, n (%) *

37 (0.5)

29 (0.5)

31 (0.7)

8 (0.5)

11 (0.3)

3 (0.2)

3 (0.4)

1 (0.3)

  1. Continuous data are presented as a median (interquartile range) and categorical data are expressed as a number (proportion)
  2. Abbreviations; BP blood pressure, eGFR estimated glomerular filtration rate, CVD cardiovascular disease;
  3. *p < 0.05 among 4 categories of alcohol consumption